Clinical Trials in Tennessee

Showing 12681-12700 of 17,345 trials

Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy

NCT01522235

The purpose of the study is to see if administering intravenous immune globulin (IVIG) (putting immune globulin directly into your blood) helps to improve the symptoms of orthostatic hypotension (sudden fall in blood pressure when a person stands up) and quality of life in men and women who have autoimmune autonomic ganglionopathy (AAG).

Autoimmune Autonomic Ganglionopathy (AAG)

Beth Israel Deaconess Medical Center6 participantsStarted Feb 2012

Bethesda, Maryland, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +3 more locations

TERMINATEDNA29 miles

PET/CT Evaluation of Treatment Response in Breast Cancer

NCT01222416

The purpose of this study is to develop Positron Emission Tomography (PET) - Computed Tomography (CT) PET/CT imaging methods for looking at the effects of chemotherapy in breast cancer.

Breast Cancer

Vanderbilt-Ingram Cancer Center50 participantsStarted Oct 2010

Nashville, Tennessee, United States

Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy

PET/CT Evaluation of Treatment Response in Breast Cancer

Find Trials by Condition in Tennessee

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease

Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

CNDO-109-AANK for AML in First Complete Remission (CR1)

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Early Life Factors and Respiratory Health in Mexico City Children

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.